X0206 3 2018-03-01 0 0001512762 Coherus BioSciences, Inc. CHRS 0001733375 Anicetti Vincent R COHERUS BIOSCIENCES, INC. 333 TWIN DOLPHIN DRIVE, SUITE 600 REDWOOD CITY CA 94065 0 1 0 0 Chief, Quality & Compliance Common Stock, $0.0001 par value 5150 D Stock Option (right to buy) 2.5005 2024-06-30 Common Stock 49988 D Stock Option (right to buy) 29.00 2025-04-01 Common Stock 50000 D Stock Option (right to buy) 17.17 2026-05-11 Common Stock 36736 D Stock Option (right to buy) 23.80 2027-05-17 Common Stock 25000 D Stock Option (right to buy) 12.70 2027-08-06 Common Stock 50000 D Stock Option (right to buy) 9.30 2027-11-15 Common Stock 25000 D Stock Option (right to buy) 10.05 2028-02-01 Common Stock 75000 D The original grant was for 59,988 shares, of which 10,000 shares have been exercised and sold. A portion of the remaining shares underlying this option are vested and exercisable as of the date hereof. The original vesting schedule is as follows: Twenty Five Percent (25%) of the shares subject to the option vest one year measured from May 27, 2014 (the "Vesting Commencement Date") and the remaining shares subject to the option vest in 36 successive, equal monthly installments thereafter on each monthly anniversary of the Vesting Commencement Date, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. A portion of the shares underlying this option are vested and exercisable as of the date hereof. The original vesting schedule is as follows: The underlying shares subject to the option vest and become exercisable in successive, equal monthly installments over four years measured from April 1, 2015, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. A portion of the shares underlying this option are vested and exercisable as of the date hereof. The original vesting schedule is as follows: The underlying shares subject to the option vest and become exercisable in successive, equal monthly installments over four years measured from May 6, 2016, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. A portion of the shares underlying this option are vested and exercisable as of the date hereof. The original vesting schedule is as follows: The underlying shares subject to the option vest and become exercisable in successive, equal monthly installments over four years measured from May 17, 2017, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. The underlying shares subject to the option vest and become exercisable over two years as follows: Fifty percent (50%) of the underlying shares subject to the option on August 6, 2018, an additional twenty-five percent (25%) of the underlying shares subject to the option on February 6, 2019 and twenty-five percent (25%) of the underlying shares subject to the option on August 6, 2019, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. A portion of the shares underlying this option are vested and exercisable as of the date hereof. The original vesting schedule is as follows: The underlying shares subject to the option vest and become exercisable in successive, equal monthly installments over four years measured from November 15, 2017, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. A portion of the shares underlying this option are vested and exercisable as of the date hereof. The underlying shares subject to the option vest and become exercisable in successive, equal monthly installments over four years measured from February 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. /s/ Jean Frederic Viret, as Attorney-in-Fact for Vincent R. Anicetti 2018-03-05